Cargando…
Convergence of EGFR glioblastoma mutations: evolution and allostery rationalizing targeted therapy
EGFR mutations display striking organ-site asymmetry and heterogeneity. We have shown that structurally diverse extracellular mutations, typical of glioblastomas, converge to a similar intermediate conformation, which can be synergistically targeted extra- and intracelullarly by antibody mAb806 and...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736128/ https://www.ncbi.nlm.nih.gov/pubmed/31528699 http://dx.doi.org/10.1080/23723556.2019.1630798 |